IMVT - Immunovant Inc (Healthcare: Biotechnology) Projected Earnings Date: 2025-11-09    (Delayed quote data   2025-09-11)
Last
 16.80		 Change
 ⇑ +0.60   (+3.70%)		 Volume
  1,735,761
Open
 16.15		 High
 17.20		 Low
 16.08
8EMA (Daily)
 16.27		 40EMA (Daily)
 15.94		 50EMA (Daily)
 15.98		 STO (Daily)
 73.333		 MACD Hist (Daily)
 0.364
8EMA (Weekly)
 16.152		 40EMA (Weekly)
 18.67		 50EMA (Weekly)
 19.62		 STO (Weekly)
 38.742		 MACD Hist (Weekly)
 0.685
Company Profile
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn).
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com